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Tick saliva is a potent inhibitor of endothelial cell proliferation and
angiogenesis
Ivo M. B. Francischetti1,*, Thomas N. Mather2, and José M. C. Ribeiro1
1 Vector Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, Rockville, MD 20892-8132, USA
2

Center for Vector-borne Disease, University of Rhode Island, Kingston, RI 02881-0804, USA

Abstract

NIH-PA Author Manuscript

We report for the first time that saliva of the hard tick and Lyme disease vector, Ixodes scapularis,
is a potent inhibitor of angiogenesis. Saliva (≤ 1:500 dilutions) or salivary gland (0.1–0.5 pairs/assay)
dose-dependently inhibits microvascular endothelial cell (MVEC) proliferation. Inhibition was also
detected with the saliva of the cattle tick Boophilus microplus but not with the salivary gland of
Anopheles gambiae, An. stephensiae, Lutzomyia longipalpis, Phlebotomus papatasi, Aedes
aegypti, Culex quinquefasciatus, and Cimex lectularius. Inhibition of MVEC proliferation by I.
scapularis saliva was accompanied by a change in cell shape (shrinkage of the cytoplasm with loss
of cell-cell interactions) and apoptosis which was estimated by expression of phosphatidylserine
using the Apopercentage dye, and by a typical pattern of chromatin margination, condensation, and
fragmentation as revealed by nuclear staining with Hoechst 33258. The effect of saliva appears to
be mediated by endothelial cell α5β1 integrin, because monoclonal antibodies against this but not
αvβ3, αvβ5, α9β1, or α2β1 integrins remarkably block its effect. In addition, SDS/PAGE shows that
saliva specifically degrades purified α5β1 but not αvβ5 or αvβ3 integrins. Incubation of saliva with
EDTA and 1,10-phenanthroline, but not phenylmethylsulfonyl fluoride (PMSF), inhibits salivadependent degradation of purified α5β1 integrin, suggesting that a metalloprotease is responsible for
the activity. Finally, saliva at ≤ 1:1,000 dilution blocks sprouting formation from chick embryo aorta
implanted in Matrigel, an in vitro model of angiogenesis. These findings introduce the concept that
tick saliva is a negative modulator of angiogenesis-dependent wound healing and tissue repair,
therefore allowing ticks to feed for days. Inhibition of angiogenesis was hitherto an unidentified
biologic property of the saliva of any blood-sucking arthropod studied so far. Its presence in tick
saliva may be regarded as an additional source of angiogenesis inhibitors with potential applications
for the study of both vector and vascular biology.
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Angiogenesis, the formation of new blood vessels, occurs as a result of the growth of capillaries
by vascular sprouting from preexisting vessels (1). Upon growth stimulation, quiescent
endothelial cells can enter into the cell cycle, migrate, degrade the underlying basement
membrane, and form a lumen. Angiogenesis is required for a variety of physiologic processes
such as embryonic development and wound healing. Wound healing involves a dynamic and
changing process that has been conveniently divided into three phases—inflammatory,
proliferative, and remodeling (2). This process is continuous; the phases overlap, and different
mechanisms occurring at different times trigger the release of chemical signals that modulate
orderly migration, proliferation, and differentiation of cells and the synthesis and degradation
of extracellular matrix (ECM) proteins (2). Of note, angiogenesis is generally considered to be
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a phenomenon that occurs during the proliferative phase of wound healing (3,4). This phase is
critical for the formation of granulation tissue, a hallmark of wound healing characterized by
proliferation of endothelial cells, fibroblast accumulation, and collagen synthesis. Accordingly,
granulation tissue provides nutrition, oxygen, and physical support for the tissue in repair (3,
4). Angiogenesis is also involved in the pathogenesis of some diseases, including cancer (3,
4).
The tick vector of Lyme disease, Ixodes scapularis, is an ectoparasite that feeds for several
days with its mouthpart embedded in the vertebrate host (5). To counteract the acute host
response (acute inflammation) that occurs minutes after injury, tick saliva contains a number
of molecules with antiinflammatory and antihemostatic properties (6–7); however, ticks feed
on blood for long periods of time (days) in contrast to mosquitoes, which take a meal in minutes
and are considered fast feeders (5). Accordingly, we have hypothesized that late host responses
to injury, such as endothelial cell-dependent wound healing (3,4) are negatively modulated by
tick saliva. We report here that I. scapularis saliva is a potent inhibitor of angiogenesis.

MATERIALS AND METHODS
Reagents
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All water used was of 18 MΩ quality produced by a MilliQ apparatus (Millipore, Bedford,
MA). Organic compounds, Hoescht 33258, propidium iodide (PI), phenylmethylsulfonyl
fluoride (PMSF), pilocarpine, polymixin B, and 1,10-phenantroline and formaldehyde were
obtained from Sigma Chemical (St. Louis, MO) or as stated. Tris-buffered saline (TBS) was
from BioSource International (Rockville, MD). Human dermal microvascular endothelial cells
(MVEC), human umbilical endothelial cells (HUVEC), endothelial cell basal medium-2
(EBM-2), fetal bovine serum, Single Quotes, Reagent Pack and Penstrep (100×) were
purchased from Cambrex (Walkersville, MD). Purified monoclonal antibodies (mAb) antiintegrin α5β1 (HA6), anti-αvβ3 (LM609), anti-αvβ5 (P1F6), and anti-α9β1 (Y9A2), in addition
to anti-α2β1 (BHA2.1), anti-α3β1 (MK1D2), anti-β1 (P4G11), anti-β2 (P4H9), anti-α1 (FB12),
anti-α2 (P1E6), anti-α3 (P1B5), anti-α4 (P1H4), anti-α5 (P1D6), anti-α6 (NKI-GoH3), antiαv (P3G8), and ascites anti-α5β1 (JBS4) were from Chemicon International (Temecula, CA).
Purified mAb anti-αvβ3 (23C6) and αvβ5 (P1F76) were from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA). Matrigel was acquired from BD Bioscience (San José, CA). Twelve-dayold chick embryo was from CBT Farms (Chestertown, MD). Pre-cast gels, See Blue molecular
weight markers, and LDS buffer were from Invitrogen (Carlsbad, CA).
Ticks, tick saliva, and other blood-sucking salivary glands
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Tick saliva was obtained by inducing partially engorged adult female I. scapularis to salivate
(3–4 days post attachment to a rabbit) into capillary tubes using the modified pilocarpine
induction method (8). Other salivary glands were obtained from mosquitoes and sandflies kept
in the insectary of the Laboratory of Malaria and Vector Research (LMVR, NIH) under the
direction of Mr. André Laughinhouse.
Human dermal MVEC and HUVEC culture
MVEC and HUVEC were purchased from Clonetics (San Diego, CA) and grown at 37°C, 5%
CO2 in T-25 flasks in the presence of EBM-2 Plus: EBM-2 containing 2% fetal bovine serum,
and Single Quotes (h-fibroblast growth factor-B, vascular endothelial growth factor, R3-insulin
growth factor, ascorbic acid, h-epidermal growth factor, hydrocortisone plus gentamycin and
amphotericin B). Trypsinization was performed using Reagent Pack (trypsin-EDTA, trypsin
neutralization solution, and HBSS) according to the manufacturer instructions (Cambrex, MD).
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Proliferation assay kit
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Cell proliferation assays were performed using the CellTiter 96 aqueous non-radioactive cell
proliferation assay kit (Promega, Madison, WI). This assay uses MTS solution containing 3(4,5-dimethylthiazol-2-yl)5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium)
and phenazine methosulphate. MTS is bioreduced by cells into a formazan product soluble in
tissue culture medium.
Cell proliferation assays
This was performed as described (9). In brief, after trypsinization, MVEC were seeded at 3.2
× 103/well in 96-well polystyrene tissue culture-treated plates (Corning Inc., Corning, NY) and
grown for 1 day in the presence of EBM-2 Plus. Then, EBM-2 Plus was replaced by 200 μL
of fresh EBM-2 Plus, and saliva was added (0–10 μL). After 3 days of incubation of MVEC
(in 200 μl of EBM-2 Plus) with saliva, 40 μl of MTS solution was added to the wells. After 4
h at 37°C, absorbance at 490 nm was measured spectrophotometrically using a Versamax
microplate reader equipped with the appropriate software (Molecular Devices, San Diego, CA).
Results were estimated as percent inhibition, considering 100% the MVEC growth in the
presence of EBM-2 Plus and 0% the growth of MVEC in the presence of supramaximal
amounts of saliva that completely prevented proliferation. LDH release was estimated using
the cytotoxicity detection kit (Roche Diagnostics, Mannheim, Germany).
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Saliva-induced change in MVEC shape and the effects of anti-integrin mAb
In 96-well plates, MVEC at 90% confluency in EBM-2 Plus (200 μl) were incubated with
saliva (5 μl) for different time points. In some experiments, MVEC were incubated for 1 h with
mAb anti-integrin (25 μg/ml) followed by addition of saliva as described above. Change in
cell shape morphology was observed using a Axiovert 200 (HAL 100) inverted fluorescence
microscope (Carl Zeiss, Jena, Germany) using an objective of 10×. Pictures were taken with
an AxioCam digital camera (camera mode in black and white; 1300 × 1030 standard mono)
coupled to the microscope. Image was handled using AxioVision 4.1 software (Carl Zeiss).
Degradation of integrins
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Purified integrins (~3 μg in 15 μl) were diluted to 30 μl in EBM-2 (containing 1.5 mM Ca2+,
and 0.02% BSA) followed by addition of 5 μl of saliva. In some experiments, Eppendorfs tubes
containing 15 μl of EBM-2 and 5 μl of saliva were incubated for 30-min with 1.5 μl EDTA
(20 mM, final concentration), 0.3 μl DMSO (1% v/v), PMSF (2.5 mM) or 1,10-phenantroline
(2.5 mM). PMSF and 1,10-phenatroline were diluted at 250 mM stock solution in DMSO
(100%, v/v). Then, purified integrin α5β1 (15 μl) was added and incubation was performed in
a thermocycler overnight at 37°C. To stop the reactions, 15 μl of LDS buffer (Invitrogen,
Carlsbad) containing SDS was added to the samples followed by heating at 80°C for 10 min.
Samples were loaded in 4% to 12% NU-PAGE pre-cast gels with MES buffer (Invitrogen,
CA). Gels were stained in 0.2% Coomassie blue, 45% methanol, 15% acetic acid, and destained
in 45% methanol, 15% acetic acid.
Membrane changes using Apopercetage dye
This was performed as described (10). In brief, MVEC were grown to 90% confluency on 96microwell plates containing EBM-2 Plus. In the day of the experiment, 2.5 μl saliva was added
to the wells in the presence of EBM-2 Plus (100 μl) and incubated for 3.5 h at 37°C, 5%
CO2. Then, 100 μl of pre-warmed EBM-2 Plus containing 5 μl Apopercentage dye (Biocolor,
Northern Ireland) was added to the wells for 30 minutes. Wells were washed 3 times with
EBM-2, and cells were observed in an inverted microscope coupled to a digital camera (Carl
Zeiss Axiovert 200). Apopercentage dye allows measurement of the expression of
phosphatidylserine on the outside surface of the cell membrane, which is therefore similar to
Thromb Haemost. Author manuscript; available in PMC 2010 June 28.
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what is measured by traditional annexin-V labelling. The transfer of phosphatidylserine to the
outside surface of the cell membrane permits the unidirectional transport of the Apopercentage
dye inside the cell, where it is retained and accumulates as a purple-red dye in apoptotic cells
which can be observed in a conventional inverted non-fluorescence microscope as described
in (10) and in the User’s manual (Biocolor).
Nuclear changes of apoptosis using Hoechst 33258 staining and fluorescence microscopy
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This was performed as reported (11). Briefly, MVEC were grown to 90% confluency on glass
coverslips placed in a 24-microwell plates containing EBM-2 Plus. In the day of the
experiment, saliva (5 μl) was added to the coverslips in the presence of EBM-2 Plus (200 μl)
and incubated for 6 h at 37°C, 5% CO2. Cells were carefully washed three times with EBM-2,
fixed with 3.7% formaldehyde (in TBS buffer, pH 7.4) for 15 min, washed with TBS and then
stained for 30 min with 25 μM Hoechst 33258 (in TBS). Coverslips were washed, removed
from the wells and briefly rinsed in distilled water. Then, precision wipes (Kimberly-Clark,
United Kingdom) were used to dry the excess liquid by touching the edge of the coverslips.
Coverslips were inverted and placed in a glass slide containing 9 μl of Vectashield mounting
medium for fluorescence (Vector Laboratories; Burlingame, CA). In some assays, cells were
treated with saliva as described above but without fixation and stained with Hoechst 33258
and propidium iodide (PI, 2.5 μg/ml). Nuclear morphologic changes were examined using an
inverted fluorescence microscopy (Carl Zeiss Axiovert 200, HAL 100) equipped with DAPI
and rhodamine filters for Hoechst 33528 and PI staining, respectively.
Aortic ring assay

NIH-PA Author Manuscript

Twelve-day-old chick eggs were cracked and the embryo removed from its surroundings. The
chick ventral was arranged side up and the head removed. Tweezers were used to lift the tissue
above the breastbone, and scissors were used to trim the tissue above the thoracic cavity to
exposure the heart and the aortic arch. The heart and aortic arch were carefully removed and
placed in PBS plus 1% Penstrep. Under the dissection microscope, excess tissue was removed,
and the clean arches were cut into ~0.8-mm pieces as described (25,33). Because the ends of
the aortas were held by forceps during the cleaning and cutting and may have been damaged,
they were discarded. Plates (96-well) were coated with 3 μl of Matrigel; after gelling, rings
were placed into the wells and sealed in place with a 2 × 10 μl overlay of Matrigel. Then, 100
μl EBM-2 with 1% Pentrep was added, followed by addition of saliva or salivary gland (up to
10 μl). Sprouting was observed for 3 days, and pictures were taken as described above using
a digital camera coupled to an inverted microscope. Each data point was assayed in triplicate,
and each experiment was repeated at least three times. A blinded observer scored outgrowth
by comparing responses with media alone (positive control) to that observed with saliva.
Results were scored as follows: ++++ (or 100%), sprouting comparable to positive control; +
++ (or 75%), significant sprouting but lower than positive control; ++ (or 25%), significant
sprouting above background levels; + (or 10%), low levels of sprouting; and ± (<10%), some
sprouting above negative control levels.

RESULTS
I. scapularis saliva inhibits proliferation of human dermal MVEC
Fig. 1A shows that saliva of the tick I. scapularis inhibits proliferation of MVEC in the presence
of EBM-2 Plus in a concentration-dependent manner, with an IC50 of ~0.5 μl of saliva per
assay (200 μl) or ~1:500 dilution. Fig. 1B shows that I. scapularis salivary glands were equally
potent with IC50 of ~0.2 pairs/assay (n = 3; not shown). Similar results were obtained using
human umbilical vein endothelial cells (HUVEC) incubated with I. scapularis saliva or salivary
gland, including the IC50 values in the same range (n = 5; not shown). Strong inhibition of
MVEC proliferation was also detected with the salivary glands of the tick Boophilus
Thromb Haemost. Author manuscript; available in PMC 2010 June 28.
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microplus (~1 pair/assay; not shown) whereas partial blockade (~35%) was attained with the
salivary gland of Rhodnius prolixus (~ 1 pair/assay, not shown). On the other hand, inhibiton
was not detected when MVEC was incubated with the salivary gland of Anopheles gambiae,
An. stephensi, Culex quinquefasciatus, Cimex lectularius, Aedes aegypti, Lutzomyia
longipalpis, or Phlebotomus papatasi (up to 2.5 pairs/assays; n = 3)(Fig. 1B).
As a control, we demonstrate that the effects of saliva are not due to pilocarpine used to induce
salivation (8) and known to reach high concentrations in this secretion (14). Accordingly,
exogenously added pilocarpine (up to 2.5 mM) did not affect MVEC proliferation (not shown).
Also, the effects of saliva are not due to contaminating LPS, known to affect MVEC. In fact,
dose-dependent inhibition of MVEC proliferation by saliva was the same regardless of the
presence of polymixin B (10 μg/ml), a reagent that binds LPS (not shown; n = 3).
I. scapularis saliva induces a dramatic change in the morphology of MVEC
Fig. 2A shows typical 80% to 90% confluent MVEC in culture. Exposure of MVEC to tick
saliva led cells to retract, round up, and detach, forming gaps among cells and multicellular
aggregates. Change in shape and refringency started 15–30 min after saliva addition (Fig. 2B,
2C), was evident after 1–2 h (Fig. 2D, 2E), and was remarkable at 6 h (Fig. 2F). The change
was characterized by shrinkage of the cytoplasm and apparent loss of cell-cell interactions
(n=10).
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Inhibition of angiogenesis by I. scapularis saliva is specifically prevented by anti-α5β1 mAb
Fig. 3, A and B, show, respectively, the effects of buffer (negative control) and saliva (positive
control) in MVEC shape after a 6-h incubation. Incubation of MVEC with mAb against antiαvβ3 (Fig. 3C), anti-αvβ5 (Fig. 3D), and anti-α9β1 (Fig. 3E) did not interfere with the effects
of saliva. In contrast, Fig. 3F shows that anti-α5β1 mAb reduced the change in cell shape
promoted by saliva. Similar results were obtained with anti-α5β1 from ascites (JBS4)(not
shown). Other anti-integrin mAb including anti-α2β1, anti-α3β1, anti-β1, anti-β2, anti-α1, antiα2, anti-α3, anti-α4, anti-α5, anti-α6, and anti-αv were consistently without effects (pictures
not shown).
I. scapularis saliva degrades integrin α5β1 and α1β1
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To further explore the mechanism of action of saliva, different integrins were incubated with
saliva in vitro in the presence of EBM-2 (1.5 mM Ca2+) followed by analysis of enzyme activity
by SDS/PAGE. Fig. 4A shows that saliva did not degrade integrins αvβ3 and αvβ5. In contrast,
Figure 4B shows that the proteolytic activity of saliva was able to degrade both α and β subunits
of integrin α5β1 and α1β1. The proteolytic effect appears to be mediated by a metalloprotease
since EDTA (20 mM), or 1,10-phenatroline (2.5 mM), but not PMSF (2.5 mM), attenuate
degradation of integrin α5β1 by saliva (Fig. 4C).
I. scapularis saliva induces apoptosis of MVEC
Based on the experimental results showing that saliva inhibits MVEC proliferation and the
change of cell shape observed under the microscope, it was plausible to suggest that apoptosis
was the mechanism mediating saliva-induced cell death. Apoptosis, or programmed cell death,
plays a fundamental role in many normal biologic processes (15). Apoptotic cells undergo an
orchestrated cascade of events characterized by distinct morphologic and biochemical changes
that take place on the cell surface, in the cytoplasm, and in the nucleus (9,15). In an attempt to
detect apoptosis, we have used the Apopercentage dye that allows measurement of the
expression of phosphatidylserine on the outside surface of the cell membrane (10,11).
Therefore this method is similar to what is measured by traditional annexin-V labeling that is
known as one of the most specific markers of apoptosis (15). Fig. 5A shows that MVEC
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incubated with saline were not stained by the Apopercentage dye confirming that these cells
are viable and non-apoptotic. In contrast, Figure 5B shows that the MVEC incubated with
saliva changed their shape and many of them stained in red-purple by the Apopercentage dye
(arrows), which is indicative of apoptosis.
A second assay was used to confirm apoptosis in these cells. Cells were incubated with saliva
for 6 hours and then stained with Hoechst 33258, a membrane-permeable dye that is specific
for nuclear DNA(see Methods). Nuclear changes are among the most sensitive markers of
apoptosis (11,15,16). Fig. 5C shows the nucleus of MVEC without treatment, which is
characterized by a smooth and regular contour. Fig. 5D shows the nucleus of saliva-treated
cells, presenting typical morphologic changes of apoptotic cells characterized by highly
condensed, marginated, and fragmented chromatin (9,11,15,17). In some experiments, MVEC
treated with saliva but not fixed were incubated with propidium iodide (PI). PI specifically
stains (red) the nucleus of cells that have lost membrane permeability due to necrosis but not
to early apoptosis. Because incubation of saliva-treated MVEC with PI was not accompanied
by red staining of the nucleus (not shown), we conclude that saliva at this concentration and
incubation time induces programmed cell death that retains an intact plasma membrane (15).
I. scapularis saliva inhibits chick aorta ring sprouting
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The sprouting of vessels from aortic ring explants was used next to determine whether the tick
saliva inhibited in vitro angiogenesis. Chick aortic rings were placed in Matrigel and incubated
with EBM-2 (100 μl). Fig. 6A shows a typical sprouting without saliva, resulting in dense
networks of sprouts. Fig. 6, B–D, shows the striking inhibitory effects of saliva that starts with
0.1 μl (1:1000 dilution) and is complete with 1 μl. Fig. 6E shows a dose-response curve for
inhibition of sprouting formation by saliva with IC50 ~0.3 μl/assay or ~1:500 dilution. Salivary
glands homogenates inhibited sprouting formation at ~0.2 pairs/assay (n = 4; not shown).
Orderly phases of wound healing are affected by tick saliva
Fig. 7 summarizes the events associated with wound healing, a characteristically dynamic and
changing process in three phases: inflammatory (inflammation), proliferative (granulation
tissue), and remodeling (wound contraction). Salivary molecules such as the coagulation
inhibitors Ixolaris (7), Penthalaris (18), (SALP14) (19)—in addition to an anti-complement
protein, ISAC (20), a salivary inhibitor of neutrophil function (6,21), and a bradykinindegrading kininase (5,22)—work in concert to effectively block the acute phase of
inflammation. On the other hand, later stages of inflammation, during which endothelial celldependent granulation tissue formation takes place, appear to be counteracted by tick salivary
components displaying anti-angiogenesis activities (see Discussion).
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DISCUSSION
We describe for the first time the identification of two novel biologic activities in tick saliva:
inhibition of endothelial cell proliferation and angiogenesis. Angiogenesis is conceptually
defined as the formation of new blood vessels from existing ones and accordingly is essentially
dependent on endothelial cells. Angiogenesis is important in a number of physiologic processes
and is particularly relevant at late stages of wound healing. Wound healing is a critical step
necessary for tissue repair and has been appropriately divided into three phases: inflammatory,
proliferative, and remodeling (see Fig. 7). Of interest, angiogenesis occurs mostly during the
proliferative phase, when formation of the so-called granulation tissue takes place. Granulation
tissue—characterized by an intense proliferation of endothelial cells, fibroblast accumulation,
and collagen synthesis—provides nutrition, oxygen, and physical support for growing tissue
(3,4).
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Because the proliferative phase of wound healing leading to granulation tissue formation starts
0.2–0.4 days after the onset of injury (3,4), and ticks feed on blood for days, it is plausible that
tick saliva contains molecules that specifically inhibit endothelial cell proliferation therefore
impairing wound healing and tissue repair. In support to this contention, here we show that
saliva and salivary gland of ticks, but not of mosquitoes or sand flies, are potent inhibitors of
MVEC proliferation (Fig. 1A). At present however, it is uncertain which molecule is
responsible for this property. Our assays using saliva suggest that an enzyme, most likely a
fibrinogen(olytic) metalloprotease, accounts for the activity. This is supported by the finding
that metalloprotease inhibitors EDTA or 1,10-phenanthroline (but not the serine protease
inhibitor PMSF) inhibits degradation of integrin α5β1 by saliva, and also by the fact that antiα5β1 antibody attenuates the change in endothelial cells shape promoted by saliva. In addition,
we have recently reported a full-length salivary gland cDNA (23) with substantial similarities
to members of the snake venoms reprolysin family of metalloproteases (24). As reported here
for tick saliva, some enzymes from this family are known to induce changes in endothelial cell
morphology and to induce apoptosis by degrading integrin α5β1 (17,24–28). Proteolytic
degradation of integrins may result in dysfunction of this receptor on the cell surface, an event
that is closely associated with apoptosis (16,29). In this regard, tick saliva induces apoptosis
of MVEC as evidenced by membrane exposure of phosphatydilserine (Fig. 5B) and by a typical
nuclear morphologic change characterized by condensation and fragmentation (Fig. 5D). As
described for venom metalloproteases (17,24–28), apoptosis appears to occur prior to cell
detachment although detachment-induced apoptosis (anoikis) can not be excluded. Finally, the
finding that saliva induces apoptosis and not necrosis is consistent with the notion that tick
saliva manipulates the host response toward a noninflammatory microenvironment at the site
of attachment (5). Indeed, it is well known that cell death by apoptosis is not associated with
the production of pro-inflammatory molecules (16).
The finding that integrin α5β1 is specifically the target of saliva is particularly important visa-vis the role of this integrin in inflammation and wound healing (3,4). The α5β1 integrin is
the major fibronectin receptor and is widely distributed (30). It is essential for cell growth and
development and it plays an active role in anchorage-dependent cell survival (31). Of note,
vascular injury is a stimulus for expression of α5β1 by vascular cells (32) and, among other
effects, α5β1 integrin function in the regulation of SMC phenotype (32), migration and
proliferation of SMC and endothelial cells (33), and leukocyte trafficking (34), in addition to
controlling fibroblast function (35), and urokinase/urokinase receptor signaling (36).
Moreover, there are many reports showing that treatment with α5β1 antagonists reduced the
vascular response after injury (37,38). These studies, along with mechanistic data derived from
cell culture experiments, provide compelling evidence that α5β1 integrin is involved in vascular
repair processes (3,4,31).
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The inhibitory effects of saliva in angiogenesis appear not to be limited to a direct apoptotic
effect in endothelial cells. Saliva has metalloprotease activity that degrades fibrin(ogen) and
fibronectin (23); both molecules are known to function as a provisional matrix and to induce
signals for endothelial cell proliferation, migration, and survival at different stages of
angiogenesis and wound healing (38–42). Accordingly, it is not surprising that sprouting
formation from chick embryo a—redundant process dependent on various pro-angiogenic
factors, ECM proteins, and different cell types—is severely affected by saliva at remarkable
diluted concentrations. Identification and expression of these molecules (e.g.,
metalloproteases) will help us to understand the mechanism by which saliva redundantly
inhibits angiogenesis. Of interest, the tick metalloprotease contains disintegrin- and cysteine
rich-like domains that are significantly smaller in size and in the number of cysteines (23) than
those in venom P-III metalloproteases (24). It may be that these structural differences account
for the specificity and mechanism of action of this enzyme (43). Finally, it should be pointed
out that Kunitz-containing proteins (44) and calreticulin (45) - known to affect MVEC
Thromb Haemost. Author manuscript; available in PMC 2010 June 28.
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proliferation, also exist in tick saliva (22). We speculate that these and other salivary molecules,
may contribute in a synergistic and redundant manner to the inhibition of angiogenesis
observed herein. Salivary molecules targeting acute inflammation (5) and compounds with
immunosuppressive properties (46,47) may also play an indirect role in allowing ticks to feed
for long periods of time.
Thus, saliva attenuates angiogenesis by at least two mechanisms: blockade of endothelial cell
integrin function leading to apoptosis, and degradation of the provisional matrix. Inhibition of
these events prevents formation of granulation tissue with inhibition of wound healing and
tissue repair, therefore allowing ticks to successfully feed on blood for days. This is in contrast
to mosquitoes and sand flies, two fast feeders species whose salivary glands appear not to affect
endothelial cell proliferation. We also suggest that other cellular components of wound healing
may be affected by tick saliva, including fibroblasts and macrophage function. Finally, we
speculate that the ability of saliva to inhibit endothelial cell proliferation may also affect
pathogen transmission by ticks (49,50). Inhibition of angiogenesis was hitherto an unidentified
biologic property of the saliva of any blood-sucking arthropods studied so far.
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FIG. 1.

I. scapularis saliva and salivary gland inhibit microvascular endothelial cell (MVEC)
proliferation: comparison with the salivary gland from other blood-sucking arthropods. MVEC
were cultured in the presence of EBM-2 Plus for 24 h at 37°C. The relative numbers of cells
in each well and the percent inhibition of proliferation were determined using MTS solution.
(A) I. scapularis saliva was added as indicated. (B) I. scapularis or other blood-sucking salivary
glands were added as indicated. No inhibition was observed with An. gambiae, An.
stephensi, Culex quinquefasciatus, Cimex lectularius, Aedes aegypti, Lutzomyia longipalpis,
or Phlebotomus papatasi salivary glands (up to 2.5 pairs/assays; n = 8). Partial inhibition was
observed with 1 pair/assay of Rhodnius prolixus salivary gland, and total inhibition was
Thromb Haemost. Author manuscript; available in PMC 2010 June 28.
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detected with ~1 pair/assay of Boophilus microplus salivary gland (not shown; n = 3). Similar
results were obtained with human umbilical vein endothelial cells (HUVEC) for all salivary
glands tested (not shown; n = 5).
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FIG. 2.

Tick saliva induces a rapid change in the morphology of MVEC. Tick saliva was added to 80%
to 90% confluent MVEC and pictures taken at the indicated time points. (A) Control (buffer,
6 h); (B) saliva (15 min); (C) saliva (30 min); (D) saliva (1 h); (E) saliva (2 h) and (F) saliva
(6 h). Magnification: 50× (n = 10).
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FIG. 3.

Treatment of endothelial cells with anti-integrin antibody prevents change on MVEC caused
by tick saliva. Tick saliva was added to 80% to 90% confluent MEVC previously incubated
for 1 h with purified mAb (25 μg/ml) when indicated: (A) buffer, no saliva; (B) saliva (5 μl);
(C) anti-αvβ3 (LM609); (D) anti-αvβ5 (P1F6); (E) anti-α9β1(Y9A2); and (F) anti-α5β1 (HA6).
Similar results were observed with anti-αvβ3 (23C6), anti-αvβ5 (P1F76) mAbs that did not
attenuate the effects of saliva, whereas inhibition was observed with ascites anti-α5β1 (JBS4)
mAb (pictures not shown). Pictures were taken after 6 hr of incubation with saliva (n = 3).
Magnification: 80×. No effects were observed when the following mAb were used: anti-α1, -
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α2, -α3, -α4, -α5, -α6, -β1, -β2, -αv, -α2β1, or -α3β1 (n = 3). mAbs alone did not affect the
MVEC shape.
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Saliva degrades purified integrin α5β1 and α1β1, but not αvβ3 or αvβ5: Effects of inhibitors.
In (A) purified integrins αvβ3 or αvβ5 were incubated with saliva overnight at 37°C in EBM-2
and no degradation was observed after SDS/PAGE and staining with 0.2% Coomassie blue (n
= 5). In (B) purified integrins α5β1 and α1β1 were incubated with saliva as in (A) and
degradation was observed for both α and β chains after SDS/PAGE and staining as above. (C)
The metalloprotease inhibitors EDTA (20 mM) or 1,10-phenanthroline (2.5 mM), and the
serine protease inhibitor PMSF (2.5 mM) were incubated for 30-min with saliva followed by
addition of integrin α5β1 and overnight incubation as in (A) followed by SDS/PAGE and
staining as above. The gel shows that degradation of α5β1 did not occur when saliva was treated
with EDTA or 1,10-phenanthroline, but was observed in the presence of PMSF (n=4). Results
are from a typical experiment.
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Tick saliva induces apoptosis in endothelial cells. (A) MVEC were incubated in the absence
or (B) presence of saliva for 4 hours and stained with Apopercentage dye (see Methods). In
(A) cells are not stained confirming its viability and non-apoptotic nature, whereas in (B)
arrows indicate the red-purple stained cells indicate apoptosis. Magnification: 50x (n=3). (C)
MVEC were incubated in the absence or (D) presence of saliva for 6 hours and stained with
Hoechst 33258 (see Methods). In (C), nuclear contour is regular and smooth, whereas in (D),
arrows indicate cells with irregular nuclear contour, with nuclear hyperchromaticity, chromatin
condensation, and fragmentation typical of apoptosis. Magnification: 200× (n = 3).
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FIG. 6.

Tick saliva inhibits sprouting formation from 12-day-old chick embryo aorta. Saliva was added
to chick embryo aorta as described. After 3 days of incubation at 37°C, 5% CO2, pictures were
taken. (A) No saliva. (B) Saliva (0.1 μl). (C) Saliva (0.3 μl). (D) Saliva (1 μl). (E) Dose-response
curve for the inhibition of sprouting formation by saliva (n = 8). Magnification: 50×.
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FIG. 7.
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Orderly phases of wound healing and the effects of salivary components. Wound healing is
divided in three phases: inflammatory (inflammation), proliferative (granulation tissue), and
remodeling (wound contraction) phases. Salivary molecules Ixolaris (7), Penthalaris (18),
SALP14 (19), ISAC (20), a salivary inhibitor of neutrophil function (6,21), and a bradykinindegrading kininase (22)—work in concert to effectively block the acute phase of inflammation.
Later stages of inflammation, during which endothelial cell-dependent granulation tissue
formation takes place, appear to be counteracted by tick salivary components displaying antiangiogenesis activities. Modified from R. A. Clark, 1991 (50).

Thromb Haemost. Author manuscript; available in PMC 2010 June 28.

